NCT02466646

Brief Summary

The purpose of this study is to determine whether full-mouth disinfection is effective in the initial periodontal treatment of generalized aggressive periodontitis on clinical parameters, gingival crevicular fluid interleukin-1β (IL-1β) and interleukin-17 (IL-17) and periodontal pathogen levels compared with conventional initial periodontal treatment and full-mouth initial periodontal treatment. The investigators' hypothesis is to test whether full-mouth disinfection in the initial periodontal treatment of generalized aggressive periodontitis enhance the clinical, biochemical and microbiological parameters in comparison to conventional initial periodontal treatment and full-mouth initial periodontal treatment.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Dec 2012

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 9, 2015

Completed
5 years until next milestone

Results Posted

Study results publicly available

June 9, 2020

Completed
Last Updated

June 9, 2020

Status Verified

May 1, 2020

Enrollment Period

1.8 years

First QC Date

May 27, 2015

Results QC Date

April 13, 2020

Last Update Submit

May 27, 2020

Conditions

Keywords

Periodontal DebridementGingival Crevicular FluidAggressive PeriodontitisInterleukin-1betaInterleukin-17Bacteria

Outcome Measures

Primary Outcomes (1)

  • Probing Depth

    6 months after initial periodontal treatment

Secondary Outcomes (11)

  • Gingival Crevicular Fluid Interleukin-1β and Interleukin-17 Levels (pg)

    Baseline, 3 and 6 months after initial periodontal treatment

  • Level of A. Actinomycetemcomitans

    Baseline, 3 and 6 months after initial periodontal treatment

  • Level of Porphyromonas Gingivalis

    Baseline, 3 and 6 months after initial periodontal treatment

  • Level of Fusobacterium Nucleatum

    Baseline, 3 and 6 months after initial periodontal treatment

  • Level of Parvimonas Micra

    Baseline, 3 and 6 months after initial periodontal treatment

  • +6 more secondary outcomes

Study Arms (3)

Full-mouth Disinfection IPT

ACTIVE COMPARATOR

Initial periodontal treatment was performed in 2 sessions with application of chlorhexidine to the intra-oral niches within 24 hours (Klorhex® Gel 1% for 10 minutes, Klorhex® Spray 0,2% and Klorhex® rinse 0,2% for 3 weeks).

Drug: Klorhex® Gel, rinse and spray

Conventional IPT

EXPERIMENTAL

Initial periodontal treatment was performed in a quadrant-wise manner at 1-week intervals.

Procedure: Conventional IPT

Full-mouth IPT

EXPERIMENTAL

Initial periodontal treatment was performed in 2 sessions within 24 hours.

Procedure: Full-mouth IPT

Interventions

Initial periodontal treatment was performed in 2 sessions with application of chlorhexidine to the intra-oral niches within 24 hours (Klorhex® Gel 1% for 10 minutes, Klorhex® Spray 0,2% and Klorhex® rinse 0,2% for 3 weeks).

Also known as: FMD
Full-mouth Disinfection IPT

Initial periodontal treatment was performed in a quadrant-wise manner at 1-week intervals.

Also known as: Q-SRP
Conventional IPT

Initial periodontal treatment was performed in 2 sessions within 24 hours.

Also known as: FM-SRP
Full-mouth IPT

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • No systemic diseases that could influence the outcome of the therapy
  • No smoking
  • No medications affecting periodontal tissues
  • No pregnancy or lactation
  • Presence of at least 15 teeth

You may not qualify if:

  • Received antibiotic treatment in the previous 3 months
  • Smokers
  • Pregnancy and lactation
  • Received periodontal treatment in the previous 6 months
  • Presence of less than 15 teeth
  • Presence of systemic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. J Clin Periodontol. 2012 Mar;39(3):284-94. doi: 10.1111/j.1600-051X.2011.01795.x. Epub 2012 Jan 4.

    PMID: 22220822BACKGROUND
  • Mongardini C, van Steenberghe D, Dekeyser C, Quirynen M. One stage full- versus partial-mouth disinfection in the treatment of chronic adult or generalized early-onset periodontitis. I. Long-term clinical observations. J Periodontol. 1999 Jun;70(6):632-45. doi: 10.1902/jop.1999.70.6.632.

    PMID: 10397519BACKGROUND
  • de Lima Oliveira AP, de Faveri M, Gursky LC, Mestnik MJ, Feres M, Haffajee AD, Socransky SS, Teles RP. Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects. J Clin Periodontol. 2012 Mar;39(3):295-302. doi: 10.1111/j.1600-051X.2011.01817.x. Epub 2011 Nov 30.

    PMID: 22126282BACKGROUND

MeSH Terms

Conditions

Aggressive Periodontitis

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Results Point of Contact

Title
Prof. Dr. Basak Dogan
Organization
Marmara University Faculty of Dentistry, Department of Periodontology

Study Officials

  • Basak Dogan, Prof. Dr.

    Marmara University, Faculty of Dentistry, Department of Periodontology

    STUDY DIRECTOR
  • Dilek Mamaklioglu, Dr.

    Marmara University, Faculty of Dentistry, Department of Periodontology

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2015

First Posted

June 9, 2015

Study Start

December 1, 2012

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

June 9, 2020

Results First Posted

June 9, 2020

Record last verified: 2020-05